Mikacin 500 mg Injection is a prescription medicine that is available as a Injection. Urinary Tract Infection are some of its major therapeutic uses. The alternative uses of Mikacin 500 mg Injection have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Mikacin 500 mg Injection. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Mikacin 500 mg Injection as well, which are listed below. Normally, these side effects of Mikacin 500 mg Injection are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
In addition, Mikacin 500 mg Injection's effect is Severe during pregnancy and Unknown for lactating mothers. In addition, Mikacin 500 mg Injection's effects on the liver, heart and kidney are discussed below in the Mikacin 500 mg Injection related warnings section.
Mikacin 500 mg Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Mikacin 500 mg Injection in conditions like Dehydration, Parkinson's Disease, Hearing Loss. Some other conditions that can be affected by Mikacin 500 mg Injection are listed in the contraindications section below.
Additionally, Mikacin 500 mg Injection may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to the above precautions for Mikacin 500 mg Injection, it is important to know that it is safe while driving, and is habit-forming.
Mikacin 500 mg Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Mikacin 500 mg Injection is used -
Moderate
Mild
Unknown
Is the use of Mikacin 500 mg Injection safe for pregnant women?
Mikacin Injection can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Mikacin 500 mg Injection safe during breastfeeding?
In the absence of any scientific study about the side effects of Mikacin Injection in breastfeeding women, information on safety of Mikacin Injection is unavailable.
What is the effect of Mikacin 500 mg Injection on the Kidneys?
Effects of Mikacin Injection on kidney can be severe. It is not safe to use it without doctor's advice.
What is the effect of Mikacin 500 mg Injection on the Liver?
Mikacin Injection has very mild side effects on the liver.
What is the effect of Mikacin 500 mg Injection on the Heart?
Mikacin Injection has very mild side effects on the heart.
Mikacin 500 mg Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Mikacin 500 mg Injection unless your doctor advises you to do so -
Is this Mikacin 500 mg Injection habit forming or addictive?
No, there is no any evidence that Mikacin 500 mg Injection is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Mikacin 500 mg Injection will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but consume Mikacin 500 mg Injection only on doctor's advice.
Is it able to treat mental disorders?
Mikacin 500 mg Injection is unable to treat or cure mental disorders.
Interaction between Food and Mikacin 500 mg Injection
It is safe to take Mikacin 500 mg Injection with food.
Interaction between Alcohol and Mikacin 500 mg Injection
It is difficult to say anything about the effect of Mikacin 500 mg Injection and alcohol. No research has been done on this yet.
No, Mikacin Injection cannot be taken with penicillin. Because penicillin inactivates the Mikacin Injection by combining the beta-lactam ring of penicillin with an amino group of this drug to form amide which is biologically inactive. For this reason Mikacin Injection should not be taken with penicillin. The chances of inactivation of this drug are higher in case of renal failure because in this case concentration of penicillin is higher in the kidney for a longer time as compared to the normal renal function.
Mikacin Injection is a prescription drug, hence do not take Mikacin Injection without consulting doctor. It can be harmful to patients to take this medicine without a doctor's advice.
Do not self-administer Mikacin Injection. It comes in the form of injection and given preferably 2 - 3 times in a day (Intravenously). Discontinuing the medicine in between may promote resistant bacteria which result in a relapse of the infection. You are recommended to complete the 7 - 10 days course even after getting symptomatic relief. In case you feel any discomfort such as hearing loss and nephrotoxicity while taking Mikacin Injection please inform your doctor immediately.
Yes, Mikacin Injection has been reported to cause ototoxicity (hearing loss or deafness) which is irreversible and may progress after discontinuation of the drug. It is a common side effect of this medicine. If you experience hearing loss or deafness after consuming or applying for this medicine, then consult your doctor and follow his/her instructions.
No, Mikacin Injection does not cause constipation in patients who are taking it. However, if you are experiencing constipation after taking this drug then inform your doctor and take precautionary methods such as eating fibrous foods to avoid constipation.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arikayce (amikacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-137
